Parabilis Medicines, Inc.

US$28.53As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PBLSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$3.524B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$35
24.04%
(57.49%)
Hold 3|7|8|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.47
0.47
0.46
0.48
9.82%
7.07%
(2.50%)
4.05%
Revenue$M
180.6
189.4
199.5
209.4
15.64%
15.55%
15.26%
15.12%
Peers (US$3.524B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.562
0.585
0.455
EBIT/Intx
4.893
0.945
0.865
Own earn%
(37.12)
83.48
61.73
Sh yield%
25.02
22.10
24.47
Owners
Insiders/Inst%
11.55
55.08
Short interest%
0.93
SBC / revenue%
0.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
22–27
$1 testx
—
Incr. ROIC%
6